MK-8242

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-8242, covering 2016-03-04 to 2016-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650) [Phase 1]